Fischer Medical Ventures Limited has informed the Exchange regarding a press release dated November 03, 2025, titled "Fischer Medical Ventures Wholly owned subsidiary Flynncare Health Innovations P ltd wins sliver medal at ARCA 2025".
FISCHER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fischer Medical Ventures' wholly owned subsidiary FlynnCare Health Innovations won a Silver Medal at the 23rd International Innovations Exhibition – ARCA 2025 held in Zagreb, Croatia from October 16–18, 2025. The award recognised FlynnCare's AI-powered Screening and Preventive Health Platform, showcased under IFIA Bharat. The exhibition featured over 400 innovations from more than 30 countries and is organised by the Union of Croatian Innovators with support from the International Federation of Inventors' Associations. FlynnCare's eHAP ecosystem covers screening across vitals, cardiovascular, lung, mental, eye, oral, women's health, cancer, and palliative care. No financial figures, order details, or business impact data were disclosed in the press release.
This is a brand and credibility achievement rather than a revenue-generating event, so it is unlikely to cause a material change in the stock price. For shareholders, it highlights international recognition of the subsidiary's AI-based preventive healthcare platform, which could support future business development and partnerships but does not translate into immediate earnings.